(December 3, 2019, 12:47 PM EST) -- WASHINGTON, D.C. — The current manufacturer of the over-the-counter heartburn drug Zantac and three former manufacturers on Nov. 27 told a federal judicial panel that they support the creation of a Zantac/ranitidine/N-nitrosodimethylamine (NDMA) multidistrict litigation (In Re: Zantac/Ranitidine NDMA Litigation, MDL Docket No. 2924, JPMDL)....